Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Stock data | 2024 | Change |
---|---|---|
Price | $47.72 | N/A |
Market Cap | $382.31M | N/A |
Shares Outstanding | 8.01M | N/A |
Employees | 95.00 | N/A |